Trial
NCT00059202
Trial of High-dose Urso in Primary Sclerosing Cholangitis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators
—
Condition
Primary Sclerosing Cholangitis
Intervention
Ursodeoxycholic Acid
Why stopped
DSMB reviewed interim analysis and terminated the study due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-03